Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively....
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1634 |
_version_ | 1797882666056417280 |
---|---|
author | V. B. Mychka I. E. Chazova |
author_facet | V. B. Mychka I. E. Chazova |
author_sort | V. B. Mychka |
collection | DOAJ |
description | Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively. The medication is safe and metabolically neutral even when administered as a long-term treatment. |
first_indexed | 2024-04-10T03:39:24Z |
format | Article |
id | doaj.art-5bbefb4f767d4bb29aab3078f4fcfbf0 |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2024-04-10T03:39:24Z |
publishDate | 2008-12-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-5bbefb4f767d4bb29aab3078f4fcfbf02023-03-13T07:23:16Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-12-017656591351Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatmentV. B. Mychka0I. E. Chazova1Институт клинической кардиологии им. А.Л. Мясникова ФГУ “Российский кардиологический научно-производственный комплекс”, г. МоскваИнститут клинической кардиологии им. А.Л. Мясникова ФГУ “Российский кардиологический научно-производственный комплекс”, г. МоскваBased on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively. The medication is safe and metabolically neutral even when administered as a long-term treatment.https://cardiovascular.elpub.ru/jour/article/view/1634сердечно-сосудистые заболеванияантагонисты кальциянифедипин гитсэффективность и безопасность |
spellingShingle | V. B. Mychka I. E. Chazova Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment Кардиоваскулярная терапия и профилактика сердечно-сосудистые заболевания антагонисты кальция нифедипин гитс эффективность и безопасность |
title | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
title_full | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
title_fullStr | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
title_full_unstemmed | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
title_short | Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment |
title_sort | benefits of a calcium antagonist nifedipine gits in arterial hypertension treatment |
topic | сердечно-сосудистые заболевания антагонисты кальция нифедипин гитс эффективность и безопасность |
url | https://cardiovascular.elpub.ru/jour/article/view/1634 |
work_keys_str_mv | AT vbmychka benefitsofacalciumantagonistnifedipinegitsinarterialhypertensiontreatment AT iechazova benefitsofacalciumantagonistnifedipinegitsinarterialhypertensiontreatment |